IVX 9.09% 0.5¢ invion limited

Cash position, page-5

  1. 147 Posts.
    lightbulb Created with Sketch. 6
    From investor presentation March 2015 for capital raising.

    Use of funds > These funds are budgeted to last until the end of Q3 2015 which will be following the expected release of pivotal clinical data relating to the INV103 (ala-Cpn10) and INV102 (nadolol) programs (anticipated within 3-4 months). It is expected that positive clinical data from one or both of these trials will position the company to negotiate a strategic investment in the company by a recognised biotech fund or provide a platform for a trade sale of the company or its assets.
 
watchlist Created with Sketch. Add IVX (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
-0.001(9.09%)
Mkt cap ! $32.12M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $56.69K 11.33M

Buyers (Bids)

No. Vol. Price($)
32 21500000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 12125188 4
View Market Depth
Last trade - 13.28pm 24/05/2024 (20 minute delay) ?
Last
0.5¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 100000
Last updated 10.04am 24/05/2024 ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.